Canada Life’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.1M Sell
305,691
-13,602
-4% -$2.64M 0.11% 161
2025
Q4
$55.4M Sell
319,293
-123,368
-28% -$22.5M 0.1% 171
2025
Q3
$83.6M Buy
442,661
+56,523
+15% +$10M 0.12% 153
2025
Q2
$69.4M Buy
386,138
+30,421
+9% +$5.28M 0.11% 175
2025
Q1
$60.3M Buy
355,717
+8,520
+2% +$1.4M 0.11% 178
2024
Q4
$52.4M Sell
347,197
-25,237
-7% -$3.93M 0.09% 198
2024
Q3
$57.9M Sell
372,434
-9,532
-2% -$1.42M 0.1% 186
2024
Q2
$52.3M Sell
381,966
-24,677
-6% -$3.38M 0.1% 191
2024
Q1
$54.2M Buy
406,643
+11,912
+3% +$1.55M 0.11% 180
2023
Q4
$54.1M Sell
394,731
-105,345
-21% -$13.8M 0.12% 171
2023
Q3
$60.9M Buy
500,076
+111,157
+29% +$14.8M 0.15% 136
2023
Q2
$55M Sell
388,919
-52,539
-12% -$7.24M 0.13% 154
2023
Q1
$62.6M Sell
441,458
-3,942
-0.9% -$564K 0.16% 131
2022
Q4
$70.1M Sell
445,400
-17,667
-4% -$2.54M 0.18% 118
2022
Q3
$56.8M Sell
463,067
-9,541
-2% -$1.26M 0.16% 120
2022
Q2
$62.9M Sell
472,608
-3,798
-0.8% -$518K 0.17% 125
2022
Q1
$68.9M Buy
476,406
+20,102
+4% +$2.8M 0.14% 144
2021
Q4
$78.8M Buy
456,304
+36,992
+9% +$5.63M 0.16% 120
2021
Q3
$61.3M Buy
419,312
+1,165
+0.3% +$170K 0.14% 143
2021
Q2
$55.2M Buy
418,147
+119,540
+40% +$15.7M 0.13% 170
2021
Q1
$38.1M Buy
298,607
+1,540
+0.5% +$190K 0.09% 233
2020
Q4
$35.3M Sell
297,067
-8,152
-3% -$994K 0.07% 290
2020
Q3
$34.9M Buy
305,219
+1,846
+0.6% +$218K 0.08% 256
2020
Q2
$34.4M Sell
303,373
-1,880
-0.6% -$199K 0.08% 245
2020
Q1
$24.7M Buy
305,253
+9,331
+3% +$966K 0.07% 283
2019
Q4
$31.4M Buy
295,922
+12,138
+4% +$1.27M 0.07% 289
2019
Q3
$30.4M Buy
283,784
+15,688
+6% +$1.61M 0.07% 292
2019
Q2
$27.3M Sell
268,096
-4,161
-2% -$400K 0.06% 311
2019
Q1
$24.4M Buy
272,257
+4,731
+2% +$410K 0.06% 283
2018
Q4
$21.5M Buy
267,526
+1,669
+0.6% +$156K 0.06% 291
2018
Q3
$28.7M Sell
265,857
-11,159
-4% -$1.22M 0.07% 272
2018
Q2
$30.5M Sell
277,016
-101,664
-27% -$10.6M 0.07% 273
2018
Q1
$38M Buy
378,680
+116,045
+44% +$11.9M 0.09% 228
2017
Q4
$25.8M Sell
262,635
-71
-0% -$6.73K 0.06% 300
2017
Q3
$24.1M Buy
262,706
+9,788
+4% +$1.04M 0.06% 307
2017
Q2
$28.1M Sell
252,918
-102,696
-29% -$10.9M 0.07% 272
2017
Q1
$34.9M Sell
355,614
-5,713
-2% -$545K 0.09% 221
2016
Q4
$33.3M Sell
361,327
-171,888
-32% -$14.8M 0.09% 219
2016
Q3
$45.1M Sell
533,215
-168,376
-24% -$14.1M 0.13% 166
2016
Q2
$56.9M Buy
701,591
+2,949
+0.4% +$225K 0.17% 135
2016
Q1
$49.9M Buy
698,642
+26,112
+4% +$1.75M 0.18% 132
2015
Q4
$47.9M Buy
672,530
+12,890
+2% +$867K 0.18% 125
2015
Q3
$40.6M Buy
659,640
+17,032
+3% +$1.19M 0.16% 144
2015
Q2
$46.5M Sell
642,608
-77,832
-11% -$5.75M 0.16% 144
2015
Q1
$55.2M Buy
720,440
+28,364
+4% +$2.03M 0.19% 126
2014
Q4
$46.3M Sell
692,076
-60,264
-8% -$3.8M 0.15% 154
2014
Q3
$45.8M Buy
752,340
+113,243
+18% +$6.98M 0.15% 151
2014
Q2
$37.4M Buy
639,097
+71,767
+13% +$4.2M 0.12% 180
2014
Q1
$32.7M Buy
567,330
+38,936
+7% +$2.09M 0.11% 193
2013
Q4
$28.5M Buy
528,394
+89,260
+20% +$5.29M 0.1% 208
2013
Q3
$27.1M Buy
439,134
+72,199
+20% +$4.32M 0.11% 192
2013
Q2
$22.3M Buy
+366,935
New +$21.9M 0.15% 132

Other funds holding DGX

Canada Life's DGX Position: Q1 2026 in Review

Canada Life reduced its Quest Diagnostics (DGX) stake by 4.3% in Q1 2026, selling an estimated $2.64M and leaving 305,691 shares worth $60.1M. The position accounts for 0.11% of the portfolio, ranked #161.

Canada Life first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.6M in Q3 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Canada Life held 305,691 shares of Quest Diagnostics worth $60.1M as of Q1 2026.
  • Canada Life sold 13,602 Quest Diagnostics shares in Q1 2026, an estimated $2.64M.
  • Quest Diagnostics made up 0.11% of Canada Life's portfolio in Q1 2026, its #161 holding.
  • Canada Life first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Quest Diagnostics position peaked at $83.6M in Q3 2025.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.